Interpretation
 1. (1) In this Regulation, “automated pharmacy system” means a mechanical system that performs operations or activities with respect to the storage and packaging of drugs or medications, and with respect to their dispensing or distribution directly to patients; “computer system” means a system to electronically create, record, store, retrieve and process data and includes any hardware and software required to permit the computer to perform appropriately; “controlled drug” means a substance set out in the Schedule to Part G of the Food and Drug Regulations under the Food and Drugs Act (Canada) and includes a substance that contains one or more controlled drugs and one or more medicinal ingredients in a recognized therapeutic dose that are not controlled drugs; “dispensary” means the area of a pharmacy where drugs are stored and prepared for dispensing and distribution and to which the public has no access, but does not include an automated pharmacy system; “document” includes a prescription, record and report; “electronic document” means data that is created, recorded or stored on any medium in or by a computer system and that can be read or received by a person or a computer system; “electronic signature” means electronic information that a person creates or adopts in order to sign a document and that is in, attached to or associated with the document; “holder of the certificate” means the person to whom a certificate of accreditation has been issued; “Manual” means the manual published by the National Association of Pharmacy Regulatory Authorities entitled “Canada’s National Drug Scheduling System” and dated September 25, 1998, as that manual is amended from time to time; “medications” means drugs and other substances usually maintained in the dispensary including substances used in the compounding of drugs; “narcotic drug” means a substance referred to in the Schedule to the Narcotic Control Regulations under the Controlled Drugs and Substances Act (Canada) or anything that contains any substance set out in that Schedule; “sell” includes offer for sale, expose for sale, have in possession for sale, and distribute, whether or not the distribution is for consideration; “signature” includes an electronic signature, and “signed” includes signed by an electronic signature; “targeted substance” means, (a) a substance that is included in Schedule I of the Benzodiazepines and Other Targeted Substances Regulation under the Controlled Drugs and Substances Act (Canada), or (b) a product or compound that contains a substance that is included in Schedule I of the Benzodiazepines and Other Targeted Substances Regulation under the Controlled Drugs and Substances Act (Canada); “verbal prescription narcotic” means a substance, (a) that contains one narcotic drug, (b) that also contains, in a recognized therapeutic dose, two or more medicinal ingredients that are not narcotic drugs, (c) that is not intended for parenteral administration, and (d) that does not contain diacetylmorphine (heroin), hydrocodone, methadone, oxycodone or pentazocine.  O. Reg. 58/11, s. 1 (1). (2) Where, in this Regulation, an obligation is placed on a pharmacy, or anything is described as being done by a pharmacy, operated by a pharmacy or held by a pharmacy, the reference extends, as the context requires, to apply to the holder of the certificate with respect to the pharmacy, the designated manager of the pharmacy, and the directors of the holder of the certificate if the holder of the certificate is a corporation.  O. Reg. 58/11, s. 1 (2).